Close Menu
    What's Hot

    Longevity & Mortality Investor Conference 2026

    May 19, 2026

    Leeds Building Society Staff Pension Scheme Completes Bulk Purchase Annuity Buy-In With Royal London

    May 18, 2026

    International Life Settlement Forum 2026

    May 18, 2026
    X (Twitter) LinkedIn
    Longevity & Mortality Investor
    • Home
    • Coverage
      1. Life Insurance Capital Solutions
      2. Life Insurance
      3. Longevity and Mortality Risk Transfer
      4. Mortality
      5. Secondary Life Markets
      6. View All

      Will the US Asset Intensive Life Reinsurance Market Continue Recent Growth Spurt?

      April 22, 2026

      Daiichi Life to Reinsure Whole Life Block with Prismic Life

      April 13, 2026

      Reporting Change to Provide Regulators With More Transparency into US/Offshore Asset-Intensive Life Reinsurance Treaties

      January 28, 2026

      Capital Markets Investors Could Be About to Get a Slice of UK Life Insurance Risk

      November 26, 2025

      Chronic Disease Onset and Cumulative Exposure: Clinical, Prognostic and Underwriting Implications

      May 13, 2026

      US Annuity Sales Notch Tenth Consecutive $100bn+ Quarter

      May 11, 2026

      Life Settlement Secondary Market Returns to Growth but Plenty of Untapped Potential Still Remains

      April 22, 2026

      EIOPA Sets Out Views on Private Equity Ownership of Life Insurers in New Consultation Paper

      March 25, 2026

      Leeds Building Society Staff Pension Scheme Completes Bulk Purchase Annuity Buy-In With Royal London

      May 18, 2026

      Too Early To Judge Impact of New Funded Reinsurance Rules on UK Pension Risk Transfer Market

      May 13, 2026
      Just Group

      Safe Computing Pension Fund Completes Bulk Purchase Annuity Buy-In With Just Group

      May 11, 2026

      Bakkavor Pension Scheme Completes Bulk Purchase Annuity Buy-In With Rothesay

      May 5, 2026

      Pricing in the Unknown: Why Mortality Models Aren’t Ready for MCED Tests Just Yet

      April 9, 2026

      Better Understanding of Alzheimer’s Is Improving Lives if Not Actuarial Assumptions – Yet

      March 25, 2026

      Business as Usual in UK Pension Risk Transfer Market Amid Record Low Mortality in England and Wales

      March 25, 2026

      Latest CMI Model Shows Further Rise in Cohort Life Expectancy

      March 11, 2026

      LISA Files Amicus Brief Highlighting Consumer Impact of Adverse Ruling Regarding Term Life Insurance Policies

      May 18, 2026

      Proprietary Reverse Mortgage Market Growth a Welcome Development for MBS Investors

      May 13, 2026

      Two Years On, PHL Variable Saga Approaches Conclusion

      May 13, 2026

      UK Equity Release Market Origination Slows To Begin 2026

      May 6, 2026

      Longevity & Mortality Investor Conference 2026

      May 19, 2026

      Leeds Building Society Staff Pension Scheme Completes Bulk Purchase Annuity Buy-In With Royal London

      May 18, 2026

      International Life Settlement Forum 2026

      May 18, 2026

      LISA Files Amicus Brief Highlighting Consumer Impact of Adverse Ruling Regarding Term Life Insurance Policies

      May 18, 2026
    • Events
    • Latest Issues

      Editor’s Letter – Volume 2, Issue 5, May 2026

      May 13, 2026

      Editor’s Letter – Volume 2, Issue 4, April 2026

      April 9, 2026

      Editor’s Letter – Volume 2, Issue 3, March 2026

      March 11, 2026

      Editor’s Letter – Volume 2, Issue 2, February 2026

      February 11, 2026

      Editor’s Letter – Volume 2, Issue 1, January 2026

      January 14, 2026
    • Contact Us
    Newsletter
    Longevity & Mortality Investor

    Q&A: Anna Bailey, Chestnut Capital Management

    Secondary Life Markets March 15, 2024By Greg Winterton
    Life Risk News Q&A
    Share
    Twitter LinkedIn Email

    Like most asset classes in the alternative credit market, the life settlement industry has had an interesting few years as macroeconomic changes have impacted fundraising and deal flow. Greg Winterton spoke to Anna Bailey, Managing Partner at asset manager Chestnut Capital Management, to get her thoughts on the current state of the space. 

    GW: Anna, let’s start with something general. What’s your view of the impact of the macroeconomic environment of the past few years on the life settlement market – on both fundraising and deal flow? 

    AB: The market is still steadily growing – not quite the way I think most participants in the market had anticipated, but there is growth year over year. In terms of deal flow, the main observation is that it has become a buyers’ market again and yields are going up because of the higher interest rate regime. Also, fund managers seem to be holding on to cash as the impact of rising rates makes it more difficult to get lending that makes sense – and they can still achieve the yields they have promised investors. With fundraising, I see more pension funds entering the market – despite the better yields on liquid credit, investors are increasingly interested in alternatives that provide higher yields. 

    GW: You penned a guest article for Life Risk News in June last year that discussed the rise in activity in smaller face value policies. Is that something that you’re still seeing, and does it still represent a medium to long term opportunity? 

    AB: Yes, this is a trend we are still seeing and some fund managers who traditionally purchased only large face are widening their parameters and buying policies with less than $1m in net death benefit (NDB). But I don’t know that the market will support any policies with an NDB of less than $100k though because the cost economics just don’t work.  

    GW: Related to the previous question – what’s your view on the increasing influence of the direct-to-consumer channel in the secondary market? Does where the policy comes from have much of an impact on your portfolio construction? 

    AB: I think the direct-to-consumer models are continuing to grow and I appreciate the education aspect of it. There are still many consumers who don’t know that they can sell their life insurance policy. With regards to portfolio construction, it doesn’t much matter whether the deal flow comes from the direct to consumer channel or the intermediated channel. What’s most important is that the origination is done well, and that it’s compliant – no cutting corners – and the insureds are cooperative. 

    GW: Many in the life settlement market comment on what they perceive as an awareness challenge among seniors. But from your perspective as an asset manager, what about the awareness at the end investor level? Is that improving – or not? 

    AB: I think investor awareness is growing. That’s a combination of an increased appetite for alternatives generally, as I mentioned earlier, which has led investors to our space as one option that they might consider, but also a greater awareness of life settlements more generally. I definitely don’t think that we are considered the ‘Wild West’ any longer but that doesn’t mean that there aren’t challenges that we face, but those challenges competition-based, as there are many different types of alternative investments available now. But I also think that speaks to the maturity of our industry; we’re often a serious consideration for an allocation now and a mature asset class should expect competitive pressures. 

    GW: Lastly, Anna, assume that there are investors reading this that are less or unfamiliar with the life settlement asset class. What’s your number one recommendation when it comes to the due diligence that they conduct on asset managers? 

    AB: My main recommendation would be to take as much time as you can to understand the nuances of the underlying asset and the specific drivers of return of it because they’re not the same as many other financial assets. For example, mortality, which is one of the fundamental pillars of our market doesn’t shift daily – sometimes, it’s not even yearly. Having a good grasp on that is key; success in our market is a marathon, not a sprint. 

    Anna Bailey is Managing Partner at Chestnut Capital Management 

    2024 - March Life Settlements Longevity Risk Q&A Volume 3 Issue 3 - March 2024
    Share. Twitter LinkedIn Email

    Related Posts

    Leeds Building Society Staff Pension Scheme Completes Bulk Purchase Annuity Buy-In With Royal London

    May 18, 2026By LMI Newsdesk

    LISA Files Amicus Brief Highlighting Consumer Impact of Adverse Ruling Regarding Term Life Insurance Policies

    May 18, 2026By LMI Newsdesk

    Two Years On, PHL Variable Saga Approaches Conclusion

    May 13, 2026By Greg Winterton

    Chronic Disease Onset and Cumulative Exposure: Clinical, Prognostic and Underwriting Implications

    May 13, 2026By Dr. Jyotsna Kamble
    Latest Issue

    Too Early To Judge Impact of New Funded Reinsurance Rules on UK Pension Risk Transfer Market

    May 13, 2026

    Proprietary Reverse Mortgage Market Growth a Welcome Development for MBS Investors

    May 13, 2026

    Two Years On, PHL Variable Saga Approaches Conclusion

    May 13, 2026

    Chronic Disease Onset and Cumulative Exposure: Clinical, Prognostic and Underwriting Implications

    May 13, 2026
    Ad

    Where Longevity and Mortality Meet the Markets
    ISSN 2978-5219

    X (Twitter) LinkedIn
    Coverage
    • Life Insurance Capital Solutions
    • Life Insurance
    • Longevity and Mortality Risk Transfer
    • Mortality Risk
    • Secondary Life Markets
    More Info
    • Home
    • About Us
    • Contact Us
    • Guest Articles
    • Submit Story Idea
    Our Newsletter
    Get the latest industry news, commentary and events from the Longevity & Mortality Investor directly into your inbox. Why not sign up today?

    © 2026 Longevity & Mortality Investor. Website by Kavells.
    • Sitemap
    • Privacy Policy
    • Copyright Notice
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.